Medical management of perimenopausal menorrhagia: an evidence-based approach
review
OA: closed
CC0
⤵ 1 in-corpus citation
AI-generated summary
This paper reviews evidence-based medical therapies for perimenopausal menorrhagia, highlighting levonorgestrel intrauterine systems as the most effective treatment among options including progestogens, oral contraceptives, tranexamic acid, mefenamic acid, danazol, and GnRH analogues.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
About one-third of women report heavy menstrual bleeding at some time in their lives. Menstrual blood loss increases with age. Menorrhagia is usually defined as heavy but regular menstrual bleeding of over 80 ml/cycle. Complaints of menorrhagia are common. Several medical therapies are suitable for perimenopausal women with either regular or irregular heavy bleeding. The most effective is intrauterine levonorgestrel. Other options are oral progestogens, the combined oral contraceptive pill, tranexamic acid, mefenamic acid, danazol and gonadotrophin-releasing hormone (GnRH) analogues. Systematic reviews and randomized controlled trials are discussed.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (1)
Cited by (1)
Source provenance
- openalex
- last seen: 2026-05-11T05:19:45.559451+00:00
License: CC0
· commercial use OK